Impact of [18F]FDG PET/CT Radiomics and Artificial Intelligence in Clinical Decision Making in Lung Cancer: Its Current Role
Open Access
- 5 March 2025
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 55 (2) , 156-166
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Feature selection methods and predictive models in CT lung cancer radiomicsJournal of Applied Clinical Medical Physics, 2022
- The “digital biopsy” in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CTEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the USJAMA Oncology, 2021
- Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2020
- Radiomics of 18F-FDG PET/CT images predicts clinical benefit of advanced NSCLC patients to checkpoint blockade immunotherapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2019
- Value of pre-therapy 18F-FDG PET/CT radiomics in predicting EGFR mutation status in patients with non-small cell lung cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2019
- Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesionsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2018
- Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgeryEuropean Journal of Nuclear Medicine and Molecular Imaging, 2017
- EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studiesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2017